MAP2K7 and lung carcinoma: These observations support previous finding in NIH3T3 cells that TIPE3 serves as a lipid transfer to activate PI3K-AKT and MEK-ERK pathways [8], and further suggest that TIPE3 may promote the growth and migration of lung cancer cells through AKT and ERK activation.